Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AHR | P35869 | 2/20 | 1.00 |
| ▸ | NOS1 | P29475 | 1/20 | 0.52 |
| ▸ | CA12 | O43570 | 1/20 | 0.50 |
| ▸ | CA9 | Q16790 | 1/20 | 0.50 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.48 |
| ▸ | PDPK1 | O15530 | 1/20 | 0.47 |
| ▸ | TNF | P01375 | 1/20 | 0.47 |
| ▸ | RIPK1 | Q13546 | 1/20 | 0.47 |
| ▸ | NR3C1 | P04150 | 1/20 | 0.43 |
| ▸ | PGR | P06401 | 1/20 | 0.43 |
| ▸ | NR3C2 | P08235 | 1/20 | 0.43 |
| ▸ | AR | P10275 | 1/20 | 0.43 |
| ▸ | PSMB8 | P28062 | 1/20 | 0.42 |
| ▸ | GRM5 | P41594 | 1/20 | 0.41 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.41 |
| ▸ | CA1 | P00915 | 1/20 | 0.41 |
| ▸ | CA2 | P00918 | 1/20 | 0.41 |
| ▸ | ITGB2 | P05107 | 1/20 | 0.41 |
| ▸ | ICAM1 | P05362 | 1/20 | 0.41 |
| ▸ | ITGAL | P20701 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Indole SCHEMBL7216540 | 0.88 | AHR (0.78) | AHRNOS1CA12CA9KEAP1 | |
| Formic Acid SCHEMBL28403706 | 0.88 | AHR (0.78) | AHRNOS1CA12CA9KEAP1 | |
| Acetic Acid SCHEMBL27461652 | 0.87 | AHR (0.75) | AHRNOS1CA12CA9KEAP1 | |
| Formic Acid Methyl Ester SCHEMBL28167541 | 0.84 | AHR (0.70) | AHRNOS1CA12CA9KEAP1 | |
| SCHEMBL10463771 | 0.83 | AHR (0.70) | AHRNOS1CA12CA9KEAP1 | |
| SCHEMBL7089560 | 0.81 | AHR (0.68) | AHRCA12CA9KEAP1PDPK1 | |
| Quinoline SCHEMBL27753517 | 0.81 | AHR (0.66) | AHRNOS1CA12CA9KEAP1 | |
| Tert-Butyl Formate SCHEMBL27751459 | 0.80 | AHR (0.64) | AHRNOS1CA12CA9KEAP1 | |
| Ethoxycarbonyl Group SCHEMBL28003566 | 0.79 | AHR (0.62) | AHRNOS1CA12CA9KEAP1 | |
| SCHEMBL9119045 | 0.78 | KEAP1 (0.62) | AHRCA12CA9KEAP1PDPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 716 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120131638-A | Application of indole compound with electron withdrawing group in inhibiting plasmid conjugation transfer | 扬州大学 | 2025-06-13 | — | — | CN | claimed |
| EP-4526426-A2 | METHODS FOR PRODUCING MONOTERPENE INDOLE ALKALOIDS | Danmarks Tekniske Universitet (DK) | 2025-03-26 | — | — | EP | claimed |
| CN-118667802-A | Method for improving stability of horseradish peroxidase | 伊莱瑞特(武汉)生物技术有限公司 | 2024-09-20 | — | — | CN | claimed |
| CN-118125960-A | Bisindole 3-ketone compound, application and preparation method thereof | 云南农业大学 | 2024-06-04 | — | — | CN | claimed |
| CN-118063373-A | 3,3' -Bisindole compound and application and preparation method thereof | 云南农业大学 | 2024-05-24 | — | — | CN | claimed |
| WO-2023222879-A2 | METHODS FOR PRODUCING MONOTERPENE INDOLE ALKALOIDS | DANMARKS TEKNISKE UNIVERSITET (DK) | 2023-11-23 | — | — | WO | claimed |
| CN-114805664-B | Bionic modified marine antifouling resin material, and preparation method and application thereof | 江苏苏博特新材料股份有限公司 | 2023-04-14 | — | — | CN | claimed |
| CN-114805664-A | Bionic modified marine antifouling resin material, and preparation method and application thereof | 江苏苏博特新材料股份有限公司 | 2022-07-29 | — | — | CN | claimed |
| CN-114292582-B | Hyperbranched coating suitable for marine concrete, and preparation method and application thereof | 江苏苏博特新材料股份有限公司 | 2022-07-12 | — | — | CN | claimed |
| CN-114292582-A | Hyperbranched coating suitable for marine concrete, and preparation method and application thereof | 江苏苏博特新材料股份有限公司 | 2022-04-08 | — | — | CN | claimed |
| CN-110372722-B | Method for synthesizing sulfur-nitrogen-containing bis-heterocyclic compound | 河南师范大学 | 2020-08-11 | — | — | CN | claimed |
| CN-111004283-A | Preparation method of 3-phosphoryl indole compound | 南京理工大学 | 2020-04-14 | — | — | CN | claimed |
| CN-106117113-A | Polysubstituted carbazole, derivant and synthetic method thereof | 湘潭大学 | 2016-11-16 | — | — | CN | claimed |
| CN-104073045-A | Application of halogenated indole and derivatives thereof as marine antifouling agent | YANTAI INST COASTAL ZONE RES CAS | 2014-10-01 | — | — | CN | claimed |
| CN-1451002-A | Indole derivatives for treating central nervous system disease | LUNDBECK & CO AS H (DK) | 2003-10-22 | — | — | CN | claimed |
| US-20260071243-A1 | BIOLOGICAL PRODUCTION OF TRYPTOPHAN-DERIVED PRODUCTS | UNIV TEXAS (US) | 2026-03-12 | — | — | US | disclosed |
| EP-3897833-B1 | INHIBITORS OF APOL1 AND METHODS OF USING SAME | VERTEX PHARMA (US) | 2026-02-04 | — | — | EP | disclosed |
| WO-1994021627-A1 | INDOLE DERIVATIVES AS DOPAMINE D4 ANTAGONISTS | MERCK SHARP & DOHME LIMITED (GB) | 1994-09-29 | — | — | WO | disclosed |
| US-4731353-A | METAL SALT OF INDOLE-2-CARBOXYLIC ACID COLOR DEVELOPER | KANZAKI PAPER MANUFACTURING COMPANY, LIMITED (JP) | 1988-03-15 | — | — | US | disclosed |
| EP-0116938-A1 | Benzoheterocyclic carbamates | USV PHARMACEUTICAL CORPORATION (US) | 1984-08-29 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260071243-A1 | BIOLOGICAL PRODUCTION OF TRYPTOPHAN-DERIVED PRODUCTS | TPH1, TPH2, SLC6A4 | AHR 148/4885NOS1 980/4885CA12 3187/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.